| # | Drug | Count |
|---|---|---|
| 0 | PYRIDOSTIGMINE BROMIDE | 6 |
| 1 | ENOXAPARIN SODIUM | 5 |
| 2 | MELATONIN | 5 |
| 3 | PREDNISONE | 5 |
| 4 | SERTRALINE | 4 |
| 5 | ALLOPURINOL | 3 |
| 6 | ATEZOLIZUMAB | 3 |
| 7 | BEVACIZUMAB | 3 |
| 8 | PREDNISOLONE | 2 |
| 9 | PREDNISOLONE ORAL | 2 |
| # | Drug | Count | Frequency |
|---|---|---|---|
| 0 | PYRIDOSTIGMINE BROMIDE | 6 | 0.0008 |
| 1 | PYRIDOSTIGMINE BROMIDE ORAL | 1 | 0.0003 |
| 2 | EFGARTIGIMOD ALFA | 1 | 0.0003 |
| 3 | MELATONIN | 5 | 0.0001 |
| 4 | ENOXAPARIN SODIUM | 5 | 0.0001 |
| 5 | ATEZOLIZUMAB | 3 | 0.0001 |
| 6 | VINCRISTINE SULFATE | 1 | 0.0000 |
| 7 | BEVACIZUMAB | 3 | 0.0000 |
| 8 | ALLOPURINOL | 3 | 0.0000 |
| 9 | CISPLATIN | 1 | 0.0000 |
| # | Drug class | Count | Frequency |
|---|---|---|---|
| 0 | Neonatal Fc Receptor Blocker [EPC] | 1 | 0.0002 |
| 1 | Xanthine Oxidase Inhibitor [EPC] | 3 | 0.0000 |
| 2 | Vascular Endothelial Growth Factor Inhibitor [EPC] | 3 | 0.0000 |
| 3 | Integrin Receptor Antagonist [EPC] | 1 | 0.0000 |
| 4 | Corticosteroid [EPC] | 8 | 0.0000 |
| 5 | Alkylating Drug [EPC] | 1 | 0.0000 |
| 6 | Platinum-based Drug [EPC] | 1 | 0.0000 |
| 7 | CD20-directed Cytolytic Antibody [EPC] | 1 | 0.0000 |